FDA Flags Five Bacteria in Hand Soaps Shipped to Workplaces in 15 States

The FDA classified an Intercon Chemical hand soap recall as Class II on September 11, after five bacteria strains were found in six soap products shipped to 20 consignees across 15 states.

Sep 17, 2026 - 01:24
0 4
FDA Flags Five Bacteria in Hand Soaps Shipped to Workplaces in 15 States

The FDA has formally classified a recall of six Intercon Chemical Co. hand soap products as a Class II action, its second-most severe alert level, 74 days after the company pulled the products voluntarily. The soap went to 20 consignees across 15 states, and much of it landed in workplaces and public facilities rather than on retail shelves. Two of the six products were recalled over five named bacterial strains.


FDA Flags Five Bacteria in Hand Soaps Shipped to Workplaces in 15 States

Washington, D.C. — The action covers 2,696 cases of foaming and liquid hand soap manufactured or distributed under five brand names, according to the FDA enforcement report registered as event 99466. No FDA press release was issued, and the recall remains ongoing with no specified end date.

What the FDA Actually Classified, and When

Intercon Chemical Co. of St. Louis, Missouri, initiated the recall voluntarily on June 29, 2026. The FDA did not classify it as a Class II action until September 11, 2026 — a gap of 74 days between the company's own action and the agency's formal risk designation.

Class II sits below Class I on the FDA's scale. WGRZ quotes the agency's definition: a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote. Quartz summarizes the same standard more plainly: exposure is unlikely to cause lasting harm, any health consequences are expected to be temporary or reversible, and the chance of a serious outcome is considered remote.

That classification is the news. Until September 11, the public record of this recall was a voluntary action by a Missouri chemical company. It is now a classified enforcement action carrying the FDA's own judgment about the risk to the people who used the soap.

The exterior signage of the U.S. Food and Drug Administration headquarters in Silver Spring, Maryland. Photo: AP Photo/Manuel Balce Ceneta

The Five Bacteria Named on the Label

Two of the six products — Intercon Foaming Pear Hand Soap With Aloe and Clearly Better by Intercon Foaming Pear Hand Soap With Aloe — were recalled for potential contamination with five named strains: Pseudomonas aeruginosa, Pseudomonas putida, Pseudomonas monteilii, Serratia marcescens and Serratia nematodiphila. The other four products were recalled for "potential bacterial contamination," with no species named.

The CDC describes Pseudomonas as a group of bacteria commonly found in the environment, including in soil and water. The most common type causing infections in humans is Pseudomonas aeruginosa, which can cause infections in the blood, lungs, urinary tract or other parts of the body, and the CDC says these infections typically occur in healthcare settings. Patients on ventilators, patients with devices such as catheters, and people with open wounds from surgery or burns face the highest risk. Some strains resist nearly all antibiotics, which makes treatment harder. The CDC also lists contaminated hands among the ways the germ spreads, and advises caregivers to clean their hands before and after caring for wounds or touching a medical device.

Cleveland Clinic describes Serratia as opportunistic bacteria that are widespread in the environment. Serratia marcescens is the primary type infectious to humans, can cause infections in the blood, lungs, urinary tract or other parts of the body, and commonly spreads in hospitals or long-term care facilities.

CDC guidance identifies Pseudomonas aeruginosa as the species most likely of the two to cause bloodstream infections, pneumonia or urinary tract infections. Serratia marcescens has been linked to a broader range of infections, including those affecting the eyes, stomach, brain, bones and heart, in addition to blood and respiratory infections. Both can exhibit resistance to common antibiotics.

Who Is Actually at Risk

Most people who washed their hands with these products will never know it. The FDA has identified the groups facing a greater likelihood of serious infection if exposed: people with compromised immune systems, people with underlying chronic conditions such as cancer or diabetes, and people who have been on extended courses of antibiotics.

For those groups the symptom list matters. Fever, unusual redness or swelling, respiratory symptoms or urinary discomfort after using a recalled soap are the triggers the recall guidance says should send someone to a healthcare provider.

The Products, the Lots and the Codes You Need

The 28.7 fluid ounce Intercon Foaming Pear Hand Soap With Aloe, UPC 789745002981, accounts for 693 cases under recall number C-0013-2026. Its lots are AF97312, 26-01001 and 26-01803, with best-by dates of Jan. 12, 2028, March 13, 2028 and March 2028. The 1,000 millilitre (34 fluid ounce) Clearly Better by Intercon Foaming Pear Hand Soap With Aloe, UPC 789745002615, accounts for 143 cases under recall number C-0014-2026, with lots 26-01001 and 26-01803 and best-by dates of March 13, 2028 and March 2028.

Summit 150 Foaming Hand Soap, 28.7 fluid ounces, UPC 810080570030, is the largest single volume at 1,040 cases. Its recall number is C-0015-2026, its lots are BF97303, BF97304 and BF97305, and its best-by dates are Feb. 3, Feb. 4 and Feb. 5, 2028. Vestis Foaming Hand Soap in Fresh Pear Scent, 33.8 fluid ounces, UPC 810080570405, accounts for 225 cases under recall number C-0016-2026, with lot 26-03091 and a best-by date of May 2028.

The two consumer-facing entries are Laura Lynn Honey Apple Crisp Liquid Hand Soap, 8 fluid ounces, UPC 086854074305, at 301 cases with lots C3576 and 26-01804 and best-by dates of Nov. 5 and March 2028, and Laura Lynn Foaming Pear Scent Hand Soap with Moisturizers, 7.5 fluid ounces, UPC 08685407408, at 294 cases under recall number C-0018-2026 with lot 26-01001.

The manufacturer of record for the two Intercon-branded products is Intercon Chemical Company, 1100 Central Industrial Drive, St. Louis, MO 63110. Summit 150 was manufactured for R.I. Williams Company of Conover, North Carolina. The Vestis product was distributed by Vestis of Roswell, Georgia. Both Laura Lynn products were distributed by Ingles Markets, Inc., of Asheville, North Carolina, which sells the Laura Lynn brand exclusively in its own supermarkets. Ingles is based in Black Mountain and is a fixture of western North Carolina grocery retail.

Most of This Soap Went to Workplaces, Not Shelves

The 20 consignees break down as 19 wholesale distributors and a single retailer, spread across California, Georgia, Illinois, Iowa, Maryland, Mississippi, Nebraska, New York, North Carolina, North Dakota, Pennsylvania, South Carolina, Texas, Washington and Wisconsin. Only the Laura Lynn line moved directly to a shop floor where an ordinary shopper could pick it up.

That distribution pattern makes this a harder recall to see. Soap in a workplace dispenser carries no UPC on the outside, no best-by date facing the user, and no reason for the person washing their hands to think about it. The burden falls on businesses in those 15 states to check their own restroom supply against the FDA's list, and on facilities managers to act on it.

Vestis, the distributor of the fresh pear foaming product, is the company formerly known as Aramark Uniform Services. It is a publicly listed provider of uniform rentals and workplace supplies serving more than 300,000 customer locations, and managed restroom supply — soap and sanitizer, dispensers, hand towels, bath tissue and air care — is one of its core service lines. Ingles Markets has offered refunds for the recalled Laura Lynn products.

The seal of the U.S. Food and Drug Administration's Office of the Commissioner. Photo: News4Jax

What the FDA Has Not Said

The published details do not say how the contamination occurred. They do not say whether the four products without named bacteria tested positive, or for what. They do not identify the individual consignees, or which cities and stores received the shipments.

Nor is there a reported illness count. As of the most recent update, the FDA had not reported any confirmed illnesses linked to the recalled products, and the published material does not say whether any cases were reported at all. A representative for Intercon Chemical Co. was not immediately available to comment.

Seventy-Four Days Between the Recall and the Warning

The 74-day interval between Intercon's voluntary action on June 29 and the FDA's Class II classification on September 11 is the spine of this story. During that period the products stayed in distribution channels — in warehouses, in dispensers, in institutional supply closets — carrying no formal risk designation from the regulator.

An unclassified voluntary recall is a company telling its customers to stop. A Class II classification is the FDA telling the public. Those are different documents, and they do not travel the same distance.

Why Contaminated Hygiene Products Keep Reaching the Market

The Intercon recall is not an isolated event in the hygiene-products sector. In August 2025, DermaRite Industries issued a voluntary nationwide recall of DermaKleen, DermaSarra, KleenFoam and other products over microbial contamination, with an FDA publish date of Aug. 9, 2025, then expanded the recall on Aug. 27, 2025 over potential Burkholderia cepacia. Those products were distributed nationwide and in Puerto Rico, and DermaRite said it had received no reports of adverse events.

Hygiene products occupy an awkward position in the supply chain. They are used on hands, in restrooms and in care settings; they are often decanted from bulk containers; and the end user has no reason to interrogate a product whose entire purpose is to make them safer. That is precisely why a Class II classification for a hand soap is not a small thing. The FDA's MedWatch program is the route for reporting adverse reactions or product quality problems.

The Artificial Tears Precedent

The most documented recent case of a contaminated hygiene product turning into an outbreak is the artificial tears episode. The CDC, working with state and local health departments, identified 81 patients in 18 states with VIM-GES-CRPA, a rare strain of extensively drug-resistant Pseudomonas aeruginosa, with specimen collection dates running from May 2022 to April 2023.

Reported adverse outcomes linked to clinical cultures included 14 patients with vision loss, four more who required enucleation, the surgical removal of the eyeball, and four deaths within 30 days of the clinical culture. CDC testing found the strain in opened EzriCare bottles from multiple lots, collected from patients with and without eye infections and from two states. FDA testing of unopened EzriCare bottles identified bacterial contamination. Isolates tested at public health laboratories were not susceptible to cefepime, ceftazidime, piperacillin-tazobactam, aztreonam, carbapenems, ceftazidime-avibactam, ceftolozane-tazobactam, fluoroquinolones, polymyxins, amikacin, gentamicin or tobramycin. EzriCare Artificial Tears was manufactured by Global Pharma Healthcare of Chennai, India.

The parallel here is not the product. It is the mechanism: a contaminated product moving through channels that obscure unit-level tracking, reaching a large number of people before a risk classification catches up with a company's own decision to pull it. In the Intercon case the FDA has reported no confirmed illnesses. The artificial tears case is what happens when that luck runs out.

What to Do If You Have It

Stop using any matching product immediately, and either discard it or return it to the place of purchase. Wash anything that may have touched it — surfaces, dispensers, containers — with non-recalled soap and hot water or in a dishwasher. Check the UPC, the lot code and the best-by date against the FDA's published list before assuming a bottle is safe because it looks ordinary.

Anyone who develops symptoms of infection after using one of these products should contact a healthcare provider, particularly anyone in the higher-risk groups. Questions about the recalled products can be directed to Intercon Chemical at its St. Louis headquarters, 1100 Central Industrial Drive, St. Louis, MO 63110.

By Jessica Ali, Staff Writer

This article was produced with AI-assisted research and editorial support. Sources: FDA Enforcement Report (event 99466), News4Jax, Asheville Citizen Times, Quartz, WGRZ, Nexstar, The Healthy, Medical Daily, WordUp News, CDC, Cleveland Clinic.

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
Jessica Ali

Editor-in-Chief at Global1.News. Atlanta-based journalist who cuts through the BS and tells it like it is. Lead anchor, host, and the voice you hear when the spin stops and the truth starts.

Comments (0)

User